The 15th European Conference on Clinical Neuroimaging will take place in Marseille, France, from March 22nd to 24th, 2027, bringing together clinicians and researchers involved in the clinical translation of brain imaging.
Following the spirit of previous ECCN meetings, the conference will provide a multidisciplinary forum across imaging modalities and will address the growing role of innovative biomarkers, quantitative methods, artificial intelligence, and emerging technologies in clinical neuroimaging.
The 2027 programme will be shaped by a “beyond” perspective, highlighting how clinical neuroimaging can move beyond conventional boundaries: [18F]FDG beyond disease-specific tracers, neuroimaging beyond the brain through brain–body interactions, cognitive and neuropsychiatric symptoms beyond classical neurodegenerative frameworks, and theranostic strategies beyond diagnostic imaging. Across these themes, particular attention will be given to connectivity and system-level interactions, to disorders with limited or absent structural correlates on morphological imaging, and to the renewed role of cerebral glucose metabolism in capturing neuron–astrocyte coupling, inflammatory processes, and network-level dysfunction.
Marseille offers a particularly meaningful setting for this meeting. Founded as Massalia on the Mediterranean shore, the city has long been a place of exchange, movement, and dialogue between cultures. This Euro-Mediterranean identity resonates strongly with the ambition of ECCN: to create a scientific crossroads where nuclear medicine, radiology, neurology, psychiatry, neuroscience, and data science can interact and contribute to the future of clinical neuroimaging.
We look forward to welcoming you to Marseille to share science, clinical experience, innovation, and collegial exchange in one of Europe’s most vibran Mediterranean cities.
Eric Guedj,
Head of the Nuclear Medicine Department – APHM; Team Leader, IMoTheP – Institut Fresnel (AMU, CNRS, Centrale Marseille)
Franck Semah,
